Stock chart for: MJN.  Currently trading at $80.57 with a 52 week high of $94.40 and a 52 week low of $65.53.

Data Provided by Thomson Reuters

NYSE | MJN (Common Stock)


 0.31 (0.38%)


10/26/16  4:00 p.m. ET

Minimum 20 minute delay

Mead Johnson has led the way in developing safe, high-quality, innovative nutrition products for more than 100 years. Today, our ongoing significant investments in scientific exploration make it possible for us to continue to expand our knowledge and turn scientific advancements into practical nutritional solutions.

Mead Johnson is the only global company primarily focused on pediatric nutrition and is a recognized world leader in this vital field. Parents, children, healthcare professionals and caregivers in North America, Latin America, Europe and Asia rely on the infant formulas, growing-up milks and specialty and solution products that we provide. And our commitment to continuous improvement and profitable long-term growth provides the foundation for building sustainable relationships with investors, customers, consumers, suppliers and other key stakeholders.

Latest Financial News


Mead Johnson Schedules Third Quarter and Nine-Month 2016 Earnings Conference Call

GLENVIEW, Ill.--(BUSINESS WIRE)--Oct. 3, 2016-- Mead Johnson Nutrition Company (NYSE: MJN) will release its third quarter and nine-month 2016 earnings on Thursday, October 27, 2016, before the market opens. The company will host

Read More


Mead Johnson to Present at the Barclays Global Consumer Staples Conference

GLENVIEW, Ill.--(BUSINESS WIRE)--Aug. 31, 2016-- Mead Johnson Nutrition Company (NYSE: MJN) announced today that it will present at the Barclays Global Consumer Staples Conference in Boston, Massachusetts on Wednesday, September

Read More

MJN: Positioned for Superior Value Creation

  • A leading global brand trusted by consumers and healthcare professionals
  • Uncompromising commitment to scientific rigor and product quality
  • Attractive long-term category growth fundamentals
  • Strong financial discipline to fund growth initiatives
  • Focused on driving sustainable, profitable long-term growth

Investor Contact Information

Investor inquiries should be directed to:

Kathy MacDonald

Kathy MacDonald

E-mail Alerts

Sign up to receive e-mail alerts whenever Mead Johnson Nutrition posts new information to the site. Just enter your e-mail address and click Submit.


Financial Reports

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.